Functionalized Nanomaterials for Cancer Therapy
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Nanomedicine and Nanotechnology".
Deadline for manuscript submissions: closed (20 April 2023) | Viewed by 1706
Special Issue Editor
Special Issue Information
Dear Colleagues,
Cancer is still an incurable disease, and traditional treatment methods, such as chemotherapy and radiotherapy, have certain limitations. The emergence of functionalized nanomaterials provides a new possibility for cancer treatment. Tumor targeting based on the enhanced permeability and retention (EPR) effect has been an important direction to reduce drug toxicity. Multifunctional nanomaterials also make combination therapy possible, such as photodynamic therapy (PDT), photothermal therapy (PTT), immunotherapy, etc. Nanomaterials are also used for visualization applications in the process of cancer treatment, such as magnetic resonance image (MRI); positron emission tomography/computed tomography (PET/CT), and fluorescence imaging (FI). Therefore, the application of functionalized nanomaterials in cancer treatment is worth summarizing, and is also expected to play a new role in the development of cancer.
Prof. Dr. Yuji Wang
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- nanomaterials
- self-assembly
- nano drug delivery system (NDDS)
- antitumor
- antimetastasis
- nanoparticle contrast agent
